Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Klaricid XL 500mg tablets
0501050B0BBAEAE
|
Klaricid | Clarithromycin | Infections | 59 |
|
Klaricid Paediatric 125mg/5ml oral suspension
0501050B0BBABAB
|
Klaricid | Clarithromycin | Infections | 9 |
|
Klaricid Adult 250mg granules sachets
0501050B0BBAFAF
|
Klaricid | Clarithromycin | Infections | 3 |
|
Klaricid Paediatric 250mg/5ml oral suspension
0501050B0BBAHAH
|
Klaricid | Clarithromycin | Infections | 1 |
|
Klaricid 250mg tablets
0501050B0BBAAAA
|
Klaricid | Clarithromycin | Infections | No data available |
|
Klaricid 500 tablets
0501050B0BBADAD
|
Klaricid | Clarithromycin | Infections | No data available |
|
Klaricid IV 500mg powder for solution for infusion vials
0501050B0BBACAC
|
Klaricid | Clarithromycin | Infections | No data available |
|
Klaricid Paediatric 125mg granules sachets
0501050B0BBAGAG
|
Klaricid | Clarithromycin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.